Literature DB >> 21276451

The ribonuclease/angiogenin inhibitor is also present in mitochondria and nuclei.

Adriana Furia1, Marco Moscato, Gaetano Calì, Elio Pizzo, Elena Confalone, Maria Rosaria Amoroso, Franca Esposito, Lucio Nitsch, Giuseppe D'Alessio.   

Abstract

The data presented here show for the first time that the protein known as "ribonuclease (RNase) inhibitor" (RI or RNH1) is present not only in the cell cytosol, but also in mitochondria, the central organelles in cell redox homeostasis. This finding directly correlates with the reported ability of RI to protect the cell from oxidative stress, with its sensitivity to oxidation and reactivity as a reactive oxygen species scavenger. While this study was carried out we also surprisingly discovered the presence of RI in the cell nucleus. We deem that these data open new views in the investigation on the cellular role(s) of the RI.
Copyright © 2011 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21276451     DOI: 10.1016/j.febslet.2011.01.034

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  14 in total

1.  Ribonuclease inhibitor 1 regulates erythropoiesis by controlling GATA1 translation.

Authors:  Vijaykumar Chennupati; Diogo Ft Veiga; Kendle M Maslowski; Nicola Andina; Aubry Tardivel; Eric Chi-Wang Yu; Martina Stilinovic; Cedric Simillion; Michel A Duchosal; Manfredo Quadroni; Irene Roberts; Vijay G Sankaran; H Robson MacDonald; Nicolas Fasel; Anne Angelillo-Scherrer; Pascal Schneider; Trang Hoang; Ramanjaneyulu Allam
Journal:  J Clin Invest       Date:  2018-03-19       Impact factor: 14.808

Review 2.  Role of the Ribonuclease ONCONASE in miRNA Biogenesis and tRNA Processing: Focus on Cancer and Viral Infections.

Authors:  Marta Menegazzi; Giovanni Gotte
Journal:  Int J Mol Sci       Date:  2022-06-12       Impact factor: 6.208

3.  Functional evolution of ribonuclease inhibitor: insights from birds and reptiles.

Authors:  Jo E Lomax; Christopher M Bianchetti; Aram Chang; George N Phillips; Brian G Fox; Ronald T Raines
Journal:  J Mol Biol       Date:  2014-06-15       Impact factor: 5.469

4.  Engineered human angiogenin mutations in the placental ribonuclease inhibitor complex for anticancer therapy: Insights from enhanced sampling simulations.

Authors:  Xiaojing Cong; Christian Cremer; Thomas Nachreiner; Stefan Barth; Paolo Carloni
Journal:  Protein Sci       Date:  2016-05-19       Impact factor: 6.725

5.  Ribonuclease/angiogenin inhibitor 1 regulates stress-induced subcellular localization of angiogenin to control growth and survival.

Authors:  Elio Pizzo; Carmen Sarcinelli; Jinghao Sheng; Sabato Fusco; Fabio Formiggini; Paolo Netti; Wenhao Yu; Giuseppe D'Alessio; Guo-Fu Hu
Journal:  J Cell Sci       Date:  2013-07-10       Impact factor: 5.285

6.  Regulation of IRE1 RNase activity by the Ribonuclease inhibitor 1 (RNH1).

Authors:  Quentin Tavernier; Evangeline Bennana; Virginie Poindessous; Celine Schaeffer; Luca Rampoldi; Nicolas Pietrancosta; Nicolas Pallet
Journal:  Cell Cycle       Date:  2018-09-05       Impact factor: 4.534

7.  PTEN modulates miR-21 processing via RNA-regulatory protein RNH1.

Authors:  Youn-Jae Kim; Se-Jeong Park; Eun Young Choi; Sol Kim; Hee Jin Kwak; Byong Chul Yoo; Heon Yoo; Seung-Hoon Lee; Daesoo Kim; Jong Bae Park; Jong Heon Kim
Journal:  PLoS One       Date:  2011-12-05       Impact factor: 3.240

8.  A nuclear-directed human pancreatic ribonuclease (PE5) targets the metabolic phenotype of cancer cells.

Authors:  Anna Vert; Jessica Castro; Marc Ribó; Antoni Benito; Maria Vilanova
Journal:  Oncotarget       Date:  2016-04-05

Review 9.  Biological Activities of Secretory RNases: Focus on Their Oligomerization to Design Antitumor Drugs.

Authors:  Giovanni Gotte; Marta Menegazzi
Journal:  Front Immunol       Date:  2019-11-26       Impact factor: 7.561

10.  Interplay between intergrin-linked kinase and ribonuclease inhibitor affects growth and metastasis of bladder cancer through signaling ILK pathways.

Authors:  Xiang Zhuang; Mengxin Lv; Zhenyu Zhong; Luyu Zhang; Rong Jiang; Junxia Chen
Journal:  J Exp Clin Cancer Res       Date:  2016-08-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.